As cases of Covid-19 increased in the UK, access to timely data was, and continues to be, a fundamental part of understanding and tackling the virus for those working within policy and research.
The programme-makers interviewed Swansea University’s Professor Ronan Lyons, Director of SAIL Databank, who summarised the insights gleaned from the rich health data in SAIL from the first peak of the virus.
A team from Population Data Science at Swansea University is to join a network of 41 partners from across 30 countries as part of the ‘Population Health Research Infrastructure’ (PHIRI), a new mechanism for organising and sharing information on COVID-19.
Led by Health Data Research UK (HDR UK), in partnership with the Office for National Statisitics, The National Core Studies programme will stimulate new, comprehensive and co-operative research efforts into COVID-19. The programme comprises six study arms; infection and surveillance, trials, transmission and environment, immunity, longitudinal health and data and connectivity.
A team from Population Data Science at Swansea University has been awarded £828,353 from the UK Research and Innovation (UKRI) COVID-19 Rapid Response Call, to help understand and address the challenges of the pandemic.
New real time analysis demonstrating the spread of Covid-19 in Wales has directly informed the One Wales response to Covid-19 in Wales.
Trusted relationships, built on strong processes, policies and a common understanding have been at the heart the rapid delivery of research intelligence for the One Wales response to COVID-19.
Since the earliest days of the COVID-19 outbreak in the UK, the SAIL Databank has played a pivotal role in the One Wales strategic response to this unprecedented global threat.
In recent times our team of data scientists have been increasingly called upon to provide valuable intelligence based on the anonymised data that we securely hold within our very own, world leading SAIL Databank.
A new International COVID-19 Data Research Alliance and Workbench will support the rapid development of therapies to combat the global effects of COVID-19. Established by Health Data Research (HDR) UK and partners, following funding announced by the COVID-19 Therapeutics Accelerator and the Gates Foundation.
